RxDoctor Payments Data

Angel Beavers

Family · Bedford, VANPI 1720404205

Payments from drug & device makers

$448in general payments, 2019–2025

Across 26 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$104
  • Bayer$82
  • Otsuka America Pharmaceutical, Inc.$42
  • Gilead$35
  • Boehringer Ingelheim$32
  • Ardelyx, Inc.$32
  • plus $121 from 6 others

What the payments were for

  • Food & beverage$448100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$448 in reported general payments places this provider in the 55th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$7,705
Medicare patients
59
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AuryxiaFerric Citrate13$42,838
FarxigaDapagliflozin Propanediol31$23,909
VelphoroSucroferric Oxyhydroxide14$23,224
Lanthanum Carbonate13$9,316
Sevelamer Carbonate36$6,584
Midodrine Hcl11$1,498
Labetalol Hcl20$901
Valsartan20$280
Amlodipine Besylate56$278
Atorvastatin Calcium12$173
Carvedilol16$110
Losartan Potassium14$57
Allopurinol11$15

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Akebia Therapeutics IncAuryxia$17$42,83813 claims
AstraZenecaFarxiga$21$23,90931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,332 family providers in Virginia.

Other family in Bedford

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →